To include your compound in the COVID-19 Resource Center, submit it here.
INDICATION: Colorectal cancer
Mouse studies suggest combining CD40 agonists and CSF1R inhibitors could help treat colorectal cancer. In two
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury